Active Ingredient (In Each Tablet)
Pseudoephedrine HCl USP 120 mg
The following Structured Product Label (SPL) was submitted to the FDA by Better Living Brands Llc for the product Pseudoephedrine Hcl (NDC 21130-158). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Pseudoephedrine HCl USP 120 mg
Nasal decongestant
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
| adults and children 12 years and over |
|
| children under 12 years | do not use this product in children under 12 years of age |
colloidal silicon dioxide, dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc, and titanium dioxide.
call 1-855-274-4122
DISTRIBUTED BY:
BETTER LIVING BRANDS LLC
P.O.BOX 99
PLEASANTON, CA 94566-0009
‡1-888-723-3929
Made in India
Code: TS/DRUGS/22/2009
Compare to the
Sudafed® 12 Hour**
active ingredient
NDC 21130-158-67
12 HOUR
MAXIMUM STRENGTH
Long-Acting
Nasal Decongestant
PSEUDOEPHEDRINE HCl
Extended-Release Tablets USP
120 mg
• SINUS PRESSURE
• CONGESTION
• NON-DROWSY
20 COATED CAPLETS*
120 mg EACH
*CAPSULE-SHAPED TABLETS
* Please review the disclaimer below.